| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 10/17/2001 | EP1144453A1 Anti-ccr4 antibodies and methods of use therefor |
| 10/17/2001 | EP1144451A2 Method of modulating cell differentiation or neoplastic trnasformation by altering cadherin-11 expression or function |
| 10/17/2001 | EP1144449A1 Reagents and methods useful for detecting diseases of the breast |
| 10/17/2001 | EP1144448A2 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor |
| 10/17/2001 | EP1144444A2 Dnas encoding proteins with signal sequences |
| 10/17/2001 | EP1144443A2 Human membrane transport proteins |
| 10/17/2001 | EP1144442A2 Streptococcal alpha2m-binding protein |
| 10/17/2001 | EP1144441A2 Disintegrin homologs |
| 10/17/2001 | EP1144439A2 Hematopoietic regulatory factors and methods of use thereof |
| 10/17/2001 | EP1144437A1 Transcription factor e2f dna-binding domain inhibitor peptides and their use |
| 10/17/2001 | EP1144004A1 Her-2 binding antagonists |
| 10/17/2001 | EP1143983A1 Spray delivery of cells |
| 10/17/2001 | EP1143982A2 Method for preparing membrane vesicles |
| 10/17/2001 | EP1143961A2 Regulators of the ptc or smoothened pathway, compositions and uses related thereto |
| 10/17/2001 | EP1143797A1 Methods for reducing adverse side effects associated with cellular transplantation |
| 10/17/2001 | EP0873405A4 Expression augmenting sequence elements (ease) for eukaryotic expression systems |
| 10/17/2001 | EP0832244A4 Polyphenol oxidase genes from lettuce and banana |
| 10/17/2001 | EP0672120B1 Production of human monoclonal antibodies active against hepatitis b surface antigen |
| 10/17/2001 | EP0610474B1 Animal cell culture |
| 10/17/2001 | EP0539563B1 Method of creating a transformed rice plant |
| 10/17/2001 | EP0489149B1 Probes for detecting mutant p53 |
| 10/17/2001 | CN1318106A Uracile permease from arabidopsis as herbicidal target gene |
| 10/17/2001 | CN1318105A Methods for down-regulating osteoprotegerin ligand activity |
| 10/17/2001 | CN1318068A Nucleic acids encoding G-protein coupled receptor involved in sensory transduction |
| 10/17/2001 | CN1317571A Method for constituting genetically engineered cell strain and bacterial strain for vaccine of hepatitis B |
| 10/17/2001 | CN1317569A Method for preparing mammal cell kinetin synthetic inhibitory factor |
| 10/17/2001 | CN1317343A Pharmaceutical Application of mammal cell kinetin synthetic inhibitory factor |
| 10/17/2001 | CN1073159C Human kunitz-type protease inhibitors and its related method |
| 10/16/2001 | US6303847 Nucleotide sequence; for transgenic plants |
| 10/16/2001 | US6303765 Polynucleotide which codes for protein of defined amino acids sequence; recombinant production; anticarcinogenic agents; antiarthritic agents; treatment of immune disorders such as multiple sclerosis and myasthenia gravis; diagnosis |
| 10/16/2001 | US6303753 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 10/16/2001 | US6303751 Human metabotropic glutamate receptor and related DNA compounds |
| 10/16/2001 | US6303380 Construction of retroviral producer cells from adenoviral and retroviral vectors |
| 10/16/2001 | US6303375 Apparatus for aggregation propagation; for use in treatment of liver; for use as artificial liver |
| 10/16/2001 | US6303371 Method of purified rAAV vector production in non-human cell line transfected with cocksackie and adenovirus receptor |
| 10/16/2001 | US6303369 Plasmid for generating preferential polypeptides; for use as a tool in genetic engineering |
| 10/16/2001 | US6303364 Bacillus thuringiensis toxins with improved activity |
| 10/16/2001 | US6303363 Method for culturing microorganisms in prefilled flexible containers |
| 10/16/2001 | US6303361 Human glandular kallikrein-1 (hK2) |
| 10/16/2001 | US6303360 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 10/16/2001 | US6303355 Method of culturing, cryopreserving and encapsulating pancreatic islet cells |
| 10/16/2001 | US6303342 Recombinant methods and materials for producing epothilones C and D |
| 10/16/2001 | US6303341 Genetically engineered antibody for use in immunotherapy |
| 10/16/2001 | US6303334 Nucleotide sequences coding polypeptides for use in as a viricide and in gene therapy |
| 10/16/2001 | US6303331 Vertebrate apoptosis gene: compositions and methods |
| 10/16/2001 | US6303330 Geranyl diphosphate synthase large subunit, and methods of use |
| 10/16/2001 | US6303327 Gene trap construct for identification and isolation of genes |
| 10/16/2001 | US6303319 Cell based assay for identifying sh2-domain-specific signal transducer antagonist |
| 10/16/2001 | US6303312 Modifying cell phenotype; medical research and therapy |
| 10/16/2001 | US6303292 Geneticlly engineered viral polypeptides; for use in diagnosis and treatment of viral infection |
| 10/16/2001 | US6303289 Composition and methods for the treatment of cancer and viral infections |
| 10/16/2001 | US6303151 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment |
| 10/16/2001 | US6303136 For cell screening and implantation into a mammalian host |
| 10/16/2001 | US6303121 Method of using human receptor protein 4-1BB |
| 10/16/2001 | US6303118 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 10/16/2001 | CA2181156C Macroencapsulated secretory cells |
| 10/16/2001 | CA2044626C Type a platelet-derived growth factor receptor gene |
| 10/16/2001 | CA2031164C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| 10/16/2001 | CA2001774C Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 10/11/2001 | WO2001075454A2 Diagnosis and treatment of alzheimer's disease |
| 10/11/2001 | WO2001075440A2 Schizophrenia related genes |
| 10/11/2001 | WO2001075435A2 Fluorescence assay for gamma-secretase activity and inhibitors |
| 10/11/2001 | WO2001075171A2 Methods, compositions and kits for the detection and monitoring of breast cancer |
| 10/11/2001 | WO2001075164A2 Rna sequence-specific mediators of rna interference |
| 10/11/2001 | WO2001075144A1 Human serine racemase |
| 10/11/2001 | WO2001075143A2 Sigma binding region of rna polymerase and uses thereof |
| 10/11/2001 | WO2001075135A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
| 10/11/2001 | WO2001075109A2 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 10/11/2001 | WO2001075094A1 Application of myeloid-origin cells to the nervous system |
| 10/11/2001 | WO2001075087A2 Subtilisin variants |
| 10/11/2001 | WO2001075084A2 Coffee mannanase |
| 10/11/2001 | WO2001075082A1 DEOXYRIBONUCLEASE IIβ PROTEINS AND cDNAs |
| 10/11/2001 | WO2001075078A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 10/11/2001 | WO2001075077A2 Isolation and expression of a gene for a nitrilase from acidovorax facilis 72w |
| 10/11/2001 | WO2001075073A2 Prostate cell lines and their use |
| 10/11/2001 | WO2001075072A2 PRODUCTION OF TcR GAMMA DELTA T CELLS |
| 10/11/2001 | WO2001075070A1 Cell culturing method and device |
| 10/11/2001 | WO2001075067A2 Novel nucleic acids and polypeptides |
| 10/11/2001 | WO2001075066A2 Dna molecules and polypeptides of pseudomonas syringae hrp pathogenicity island and their uses |
| 10/11/2001 | WO2001075064A2 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 10/11/2001 | WO2001074904A2 G-protein coupled receptors and nucleic acids encoding same |
| 10/11/2001 | WO2001074903A2 CD20/IgE-RECEPTOR LIKE MOLECULES AND USES THEREOF |
| 10/11/2001 | WO2001074902A2 Adenine binding g protein coupled receptors |
| 10/11/2001 | WO2001074899A1 Dna molecules encoding ligand gated ion channels from dermacentor variabilis |
| 10/11/2001 | WO2001074896A1 Human polynucleotides, polypeptides, and antibodies |
| 10/11/2001 | WO2001074884A1 Dermacentor variabilis gaba-gated chloride channels |
| 10/11/2001 | WO2001074859A2 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 10/11/2001 | WO2001074857A2 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 10/11/2001 | WO2001074856A2 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 10/11/2001 | WO2001074855A2 Compositions and methods for dendritic cell-based immunotherapy |
| 10/11/2001 | WO2001074845A2 Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof |
| 10/11/2001 | WO2001074841A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 10/11/2001 | WO2001074838A1 Dna molecules encoding l-glutamate-gated chloride channels from rhipicephalus sanguineus |
| 10/11/2001 | WO2001074837A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 10/11/2001 | WO2001074836A1 Novel bone marrow nucleic acids and polypeptides |
| 10/11/2001 | WO2001074378A2 Promoting cell growth by inhibiting enabled proteins or their ligands |
| 10/11/2001 | WO2001074299A2 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 10/11/2001 | WO2001074164A1 Methods of modulating hair growth |
| 10/11/2001 | WO2001036640A3 Human fgf-21 gene and gene expression products |
| 10/11/2001 | WO2001032702A9 Molecular structure of rhd negative locus |